298 related articles for article (PubMed ID: 24210068)
1. Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.
Nikolic K; Filipic S; Smoliński A; Kaliszan R; Agbaba D
J Pharm Pharm Sci; 2013; 16(4):622-47. PubMed ID: 24210068
[TBL] [Abstract][Full Text] [Related]
2. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
Vucicevic J; Nikolic K; Dobričić V; Agbaba D
Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
[TBL] [Abstract][Full Text] [Related]
3. Use of biopartitioning micellar chromatography and RP-HPLC for the determination of blood-brain barrier penetration of α-adrenergic/imidazoline receptor ligands, and QSPR analysis.
Vucicevic J; Popovic M; Nikolic K; Filipic S; Obradovic D; Agbaba D
SAR QSAR Environ Res; 2017 Mar; 28(3):235-252. PubMed ID: 28332439
[TBL] [Abstract][Full Text] [Related]
4. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
Hou TJ; Xu XJ
J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
[TBL] [Abstract][Full Text] [Related]
5. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
Shityakov S; Neuhaus W; Dandekar T; Förster C
Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
[TBL] [Abstract][Full Text] [Related]
6. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
Stępnik KE; Malinowska I
J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
[TBL] [Abstract][Full Text] [Related]
7. Computer Assisted Models for Blood Brain Barrier Permeation of 1, 5-Benzodiazepines.
Dhavale RP; Choudhari PB; Bhatia MS
Curr Comput Aided Drug Des; 2021; 17(2):187-200. PubMed ID: 32003700
[TBL] [Abstract][Full Text] [Related]
8. Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters.
Mensch J; Jaroskova L; Sanderson W; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Int J Pharm; 2010 Aug; 395(1-2):182-97. PubMed ID: 20635475
[TBL] [Abstract][Full Text] [Related]
9. Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.
Muehlbacher M; Spitzer GM; Liedl KR; Kornhuber J
J Comput Aided Mol Des; 2011 Dec; 25(12):1095-106. PubMed ID: 22109848
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-retention relationship of selected imidazoline derivatives on α1-acid glycoprotein column.
Filipic S; Ruzic D; Vucicevic J; Nikolic K; Agbaba D
J Pharm Biomed Anal; 2016 Aug; 127():101-11. PubMed ID: 26968888
[TBL] [Abstract][Full Text] [Related]
11. A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations.
Carpenter TS; Kirshner DA; Lau EY; Wong SE; Nilmeier JP; Lightstone FC
Biophys J; 2014 Aug; 107(3):630-641. PubMed ID: 25099802
[TBL] [Abstract][Full Text] [Related]
12. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
Grumetto L; Russo G; Barbato F
Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
[TBL] [Abstract][Full Text] [Related]
13. A new descriptor via bio-mimetic chromatography and modeling for the blood brain barrier (Part II).
Kouskoura MG; Piteni AI; Markopoulou CK
J Pharm Biomed Anal; 2019 Feb; 164():808-817. PubMed ID: 29884296
[TBL] [Abstract][Full Text] [Related]
14. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method.
Narayanan R; Gunturi SB
Bioorg Med Chem; 2005 Apr; 13(8):3017-28. PubMed ID: 15781411
[TBL] [Abstract][Full Text] [Related]
15. Computational models to predict blood-brain barrier permeation and CNS activity.
Subramanian G; Kitchen DB
J Comput Aided Mol Des; 2003 Oct; 17(10):643-64. PubMed ID: 15068364
[TBL] [Abstract][Full Text] [Related]
16. Insights for predicting blood-brain barrier penetration of CNS targeted molecules using QSPR approaches.
Fan Y; Unwalla R; Denny RA; Di L; Kerns EH; Diller DJ; Humblet C
J Chem Inf Model; 2010 Jun; 50(6):1123-33. PubMed ID: 20578728
[TBL] [Abstract][Full Text] [Related]
17. Study of retention parameters obtained in RP-TLC system and their application on QSAR/QSPR of some alpha adrenergic and imidazoline receptor ligands.
Eríc S; Pavlović M; Popović G; Agbaba D
J Chromatogr Sci; 2007 Mar; 45(3):140-5. PubMed ID: 17462128
[TBL] [Abstract][Full Text] [Related]
18. Investigating the utility of momentum-space descriptors for predicting blood-brain barrier penetration.
Al-Fahemi JH; Cooper DL; Allan NL
J Mol Graph Model; 2007 Oct; 26(3):607-12. PubMed ID: 17300970
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-mobility relationship analysis of imidazoline receptor ligands in CDs-mediated CE.
Filipic S; Nikolic K; Vovk I; Krizman M; Agbaba D
Electrophoresis; 2013 Feb; 34(3):471-82. PubMed ID: 23161743
[TBL] [Abstract][Full Text] [Related]
20. ADME properties evaluation in drug discovery: in silico prediction of blood-brain partitioning.
Zhu L; Zhao J; Zhang Y; Zhou W; Yin L; Wang Y; Fan Y; Chen Y; Liu H
Mol Divers; 2018 Nov; 22(4):979-990. PubMed ID: 30083853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
